researchnewsjob opportunity  
Our Mission
MGVS develops therapeutic
products that address heart and blood vessel disorders.
Our products uniquely target “no option patients” who cannot be treated adequately with current therapeutic modalities.
Leading products 
  MultiGene Angio:
cell therapy product for alleviating symptoms and signs of  ischemia in patients
peripheral arterial disease (PAD) and coronary artery
disease (CAD). 

   MultiGene Graft:
A biosynthetic vascular graft providing improved biocompatibility for renal disease patients who need an access site for hemodialysis.



Best viewed in 1024x768 resolution